Skip to content

Andrey V. Dolinko, M.D.

NPI 1811346141ActiveIndividual· Obstetrics & Gynecology, Reproductive Endocrinology· Providence, RI

Obstetrics & Gynecology, Reproductive Endocrinology (M.D.) in Providence, Rhode Island, licensed in RI, with an NPI issued in June 2016. Enrolled in Medicare as practitioner - obstetrics/gynecology. Tarsus Pharmaceuticals, Inc. reported $79.77 in payments in 2025, mostly food and beverage.

Overview

NPI1811346141
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedJun 7, 2016
Last updated in NPPESDec 8, 2023
Certified by providerDec 8, 2023

Specialties and licenses

TaxonomyCodeLicenseState
Obstetrics & Gynecology, Reproductive Endocrinology Primary207VE0102XMD18950RI

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 4, 2026No match—
New York OMIG · Nov 4, 2026No match—
Ohio Medicaid · Nov 4, 2026No match—
Pennsylvania Medicheck · Nov 4, 2026No match—
Washington HCA · Nov 4, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Obstetrics/Gynecology (RI)

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$79.77 · 1 payment from 1 company
  • 2024$163.02 · 2 payments from 2 companies

Top paying companies in 2025

CompanyAmountPayments
Tarsus Pharmaceuticals, Inc.$79.771

What the 2025 payments were for

  • Food and Beverage$79.77 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Obstetrics & Gynecology, Reproductive Endocrinology providers in Providence

All Obstetrics & Gynecology, Reproductive Endocrinology providers in Rhode Island →